01:28
Creating Drugs at the Speed of AI | Absci
13:52
Target discovery via a reverse immunology approach
04:54
Applying AI to discover novel chaperones & increase biological production
46:24
Absci Invites | Fast, Accurate Antibody Structure Prediction from Deep Learning
45:06
Absci Invites | DeepChem: Towards Open Source Foundations for Modern Drug Discovery
21:41
Sean McClain Interview with Amy Webb at Built with Bio 2022
10:33
Sean McClain and Frank Tate at Built with Biology 2022
56:25
Absci Invites | EquiBind: Geometric Deep Learning for Drug Binding Structure Prediction
25:03
Absci Lead AI Scientist Joshua Meier presents at NVIDIA GTC 2022
56:05
Truist AI Symposium Workshop: Data meets deep learning for in silico biologics with Absci
41:40
Absci Founder & CEO Sean McClain Presents at the J.P. Morgan 40th Annual Healthcare Conference 2022
56:02
Founder-Led Biotech Summit: Fireside Chat with Sean McClain
02:37
Life Science Washington: Innovation Beyond the Puget Sound
X
About
We are a generative AI drug creation company on a mission to create better biologics for patients, faster.
Tags